Evidence map›Paper›PMID 30541633›Full record

ReviewJournal of neuroinflammation2018

Methamphetamine neurotoxicity, microglia, and neuroinflammation.

Fatemeh Shaerzadeh, Wolfgang J Streit, Soomaayeh Heysieattalab, Habibeh Khoshbouei

Open access · goldAbstract readReview
In one paragraph

Review in Journal of neuroinflammation, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 69 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
69citing papers in PubMed, 3 pooled it
5.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

69 citing papers in PubMed, 3 syntheses or guidelines pooled it, 155 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Randomized, Placebo-Controlled Trial of Targeting Neuroinflammation with Ibudilast to Treat Methamphetamine Use Disorder.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2020
    Trial
  6. Trial
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

9 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Fatemeh ShaerzadehDepartment of Neuroscience, University of Florida College of Medicine and McKnight Brain Institute, JHM Health Science Center, PO Box 100244, Gainesville, FL, 32610, USA.
Wolfgang J StreitDepartment of Neuroscience, University of Florida College of Medicine and McKnight Brain Institute, JHM Health Science Center, PO Box 100244, Gainesville, FL, 32610, USA. streit@mbi.ufl.edu.
Soomaayeh HeysieattalabCognitive Neuroscience Division, Faculty of Education and Psychology, University of Tabriz, Tabriz, Iran.
Habibeh KhoshboueiDepartment of Neuroscience, University of Florida College of Medicine and McKnight Brain Institute, JHM Health Science Center, PO Box 100244, Gainesville, FL, 32610, USA.
Florida College · USUniversity of Florida · USUniversity of Tabriz · IR

Funding

Methamphetamine regulates the dopamine transporter via an intracellular mechanismR01DA026947 · NIDA · UNIVERSITY OF FLORIDA · PI KHOSHBOUEI, HABIBEH · 2010 to 2019
$3.5M
Nikon A1R two-photon microscope for a shared resourceS10OD020026 · OD · UNIVERSITY OF FLORIDA · PI KHOSHBOUEI, HABIBEH · 2015 to 2015
$600k
Functional interplay between D2 autoreceptor and dopamine transporterR21NS103108 · NINDS · UNIVERSITY OF FLORIDA · PI KHOSHBOUEI, HABIBEH, STREIT, WOLFGANG J · 2018 to 2019
$419k
Interactions between microglia and dopaminergic neurons regulates dopamine neurotransmissionR21DA043895 · NIDA · UNIVERSITY OF FLORIDA · PI KHOSHBOUEI, HABIBEH, STREIT, WOLFGANG J · 2017 to 2018
$415k
National Institutes of Health DA026947National Institutes of Health DA043895National Institutes of Health NS103108NIDA NIH HHS R01 DA026947NIDA NIH HHS R21 DA043895NIH HHS S10 OD020026NINDS NIH HHS R21 NS103108
6 · The paper itself

Abstract

Methamphetamine (METH) is an illicit psychostimulant that is subject to abuse worldwide. While the modulatory effects of METH on dopamine neurotransmission and its neurotoxicity in the central nervous system are well studied, METH's effects on modulating microglial neuroimmune functions and on eliciting neuroinflammation to affect dopaminergic neurotoxicity has attracted considerable attention in recent years. The current review illuminates METH-induced neurotoxicity from a neuropathological perspective by summarizing studies reporting microglial activation after METH administration in rodents. Assessing microglial reactivity in terms of the cells' morphology and immunophenotype offers an opportunity for comprehensive and objective assessment of the severity and nature of METH-induced neuronal perturbations in the CNS and can thus contribute to a better understanding of the nature of METH toxicity. We reach the conclusion here that the intensity of microglial activation reported in the majority of animal models after METH administration is quite modest, indicating that the extent of dopaminergic neuron damage directly caused by this neurotoxicant is relatively minor. Our conclusion stands in contrast to claims of excessive and detrimental neuroinflammation believed to contribute and exacerbate METH neurotoxicity. Thus, our analysis of published studies does not support the idea that suppression of microglial activity with anti-inflammatory agents could yield beneficial effects in terms of treating addiction disorders.

Indexed as

Neurotoxicity SyndromesAnimalsCentral Nervous System StimulantsEncephalitisHumansMethamphetamineMicrogliaCentral Nervous System StimulantsMethamphetamineDopamineMethamphetamineMicrogliaNeuroimmune

Identifiers

PMID30541633
PMCPMC6292109
OpenAlexW2905379358

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.